Health Canada grants Lactobacillus helveticus LAFTI®L10 new health claims for active adults

April 2018 – Montreal, Canada. Lallemand Health Solutions is pleased to announce a new regulatory breakthrough.

Health Canada has granted two new health claims for the probiotic strain Lactobacillus helveticus LAFTI® L10 for active adults. Claims such as “Promotes gastrointestinal health in physically active adults” and “Helps reduce the incidence of cold-like symptoms in adults with exercise-induced stress” are now available for this unique probiotic strain. This confirms the value and benefits of L. helveticus LAFTI® L10 for active adults and sports nutrition, as backed-up by four clinical studies among which two focusing on athletes’ population.

There is a growing interest in probiotics for sports nutrition market. Athletes’ population is recognized as a good model to document their effects on natural defenses in adults in general and obviously in athletes in particular. L. helveticus LAFTI® L10, with four clinical studies and several in vitro and in vivo mechanistic studies, is the first clinically tested probiotic strain demonstrating support for athletes’ immune health. In a recent study, (Marinkovic et al. 2016), L. helveticus LAFTI® L10 significantly shortened the duration of URTI-like episodes by 3.4 days (p=0.047) and normalized the CD4+/CD8+ ratio (p=0.020).

 

Contact Lallemand Health Solutions for more information on the potential of probiotics and microflora management in sports nutrition.

Clancy et al. Reversal in fatigued athletes of a defect in interferon γ secretion after administration of Lactobacillus acidophilus. Br J Sports Med 2006; 40:351–354;

Marinkovic D. et al. (2016) Lactobacillus helveticus Lafti® L10 supplementation reduces respiratory infection duration in a cohort of elite athletes: a randomized double-blind placebo-controlled trial. Applied Physiology, Nutrition, and Metabolism, 10.1139/apnm-2015-0541

 

About Lallemand Health Solutions

Backed by a rich history and 80 years of expertise in probiotic research and development, Lallemand Health Solutions offers a full line of ready-to-market probiotic formulas and helps its partners to design their own custom & complex formulations using Harmonium, LAFTI® or Rosell® Probiotic strains together with our proprietary protective technologies. Because, from the lab to the shelf, Lallemand Health Solutions controls the overall manufacturing process of its products, the company can ensure customers are receiving the highest quality standard of probiotic formulation. Cooperation spells success: we provide our partners with the full support they need to develop, register, and market their products in their own market, making Lallemand Health Solutions a complete probiotic solutions provider.

Lallemand Health Solutions covers more than 60 countries across five continents and is ready to service your probiotic needs.

For more information, please visit www.lallemand-health-solutions.com

 

Contact:                                                                                          Media Relations:

Bérengère Feuz                                                                               Sylvie Roquefeuil

Marketing Group Manager                                                           Press Officer

Tel.: +33 (0)5 62 74 5555                                                             Tel.: +33 (0) 6 84 72 76 10

Email: healthsolutions@lallemand.com                                     Email: sroquefeuil@lallemand.com